Mental health services around the world are stretched thinner than ever. Long wait times, barriers to accessing care and rising rates of depression and anxiety have made it harder for people to get timely help.
As a result, governments and health care providers are looking for new ways to address this problem. One emerging solution is the use of AI chatbots for mental health care.
A recent study explored whether a new type of AI chatbot, named Therabot, could treat people with mental illness effectively. The findings were promising: not only did participants with clinically significant symptoms of depression and anxiety benefit, those at high-risk for eating disorders also showed improvement. While early, this study may represent a pivotal moment in the integration of AI into mental health care.
AI mental health chatbots are not new—tools like Woebot and Wysa have already been released to the public and studied for years. These platforms follow rules based on a user’s input to produce a predefined approved response.
What makes Therabot different is that it uses generative AI—a technique where a program learns from existing data to create new content in response to a prompt. Consequently, Therabot can produce novel responses based on a user’s input like other popular chatbots such as ChatGPT, allowing for a more dynamic and personalized interaction.
This isn’t the first time generative AI has been examined in a mental health setting. In 2024, researchers in Portugal conducted a study where ChatGPT was offered as an additional component of treatment for psychiatric inpatients.
The research findings showed that just three to six sessions with ChatGPT led to a significantly greater improvement in quality of life than standard therapy, medication and other supportive treatments alone.
Together, these studies suggest that both general and specialized generative AI chatbots hold real potential for use in psychiatric care. But there are some serious limitations to keep in mind. For example, the ChatGPT study involved only 12 participants—far too few to draw firm conclusions.
In the Therabot study, participants were recruited through a Meta Ads campaign, likely skewing the sample toward tech-savvy people who may already be open to using AI. This could have inflated the chatbot’s effectiveness and engagement levels.
Ethics and Exclusion
Beyond methodological concerns, there are critical safety and ethical issues to address. One of the most pressing is whether generative AI could worsen symptoms in people with severe mental illnesses, particularly psychosis.
A 2023 article warned that generative AI’s lifelike responses, combined with most people’s limited understanding of how these systems work, might feed into delusional thinking. Perhaps for this reason, both the Therabot and ChatGPT studies excluded participants with psychotic symptoms.
But excluding these people also raises questions of equity. People with severe mental illness often face cognitive challenges—such as disorganized thinking or poor attention—that might make it difficult to engage with digital tools.
Ironically, these are the people who may benefit the most from accessible, innovative interventions. If generative AI tools are only suitable for people with strong communication skills and high digital literacy, then their usefulness in clinical populations may be limited.
There’s also the possibility of AI “hallucinations”—a known flaw that occurs when a chatbot confidently makes things up—like inventing a source, quoting a nonexistent study, or giving an incorrect explanation. In the context of mental health, AI hallucinations aren’t just inconvenient, they can be dangerous.
That’s what makes these early findings both exciting and cautionary. Yes, AI chatbots might offer a low-cost way to support more people at once, but only if we fully address their limitations.
Effective implementation will require more robust research with larger and more diverse populations, greater transparency about how models are trained and constant human oversight to ensure safety. Regulators must also step in to guide the ethical use of AI in clinical settings.
With careful, patient-centered research and strong guardrails in place, generative AI could become a valuable ally in addressing the global mental health crisis—but only if we move forward responsibly.
News
New study reveals molecular basis of Long COVID brain fog
Even though many years have passed since the start of the COVID-19 pandemic, the effects of infection with SARS-CoV-2 are not completely understood. This is especially true for Long COVID, a chronic condition that [...]
Scientists make huge Parkinson’s breakthrough as they discover ‘protein trigger’
Scientists have, for the first time, directly visualised the protein clusters in the brain believed to trigger Parkinson's disease, bringing them one step closer to potential treatments. Parkinson's is a progressive incurable neurological disorder [...]
Alpha amino acids’ stability may explain their role as early life’s protein building blocks
A new study from the Hebrew University of Jerusalem published in the Proceedings of the National Academy of Sciences sheds light on one of life's greatest mysteries: why biology is based on a very specific set [...]
3D bioprinting advances enable creation of artificial blood vessels with layered structures
To explore possible treatments for various diseases, either animal models or human cell cultures are usually used first; however, animal models do not always mimic human diseases well, and cultures are far removed [...]
Drinking less water daily spikes your stress hormone
Researchers discovered that people who don’t drink enough water react with sharper cortisol spikes during stressful events, explaining why poor hydration is tied to long-term health risks. A recent study in the Journal of Applied [...]
Nanomed Trials Surge Highlighting Need for Standardization
Researchers have identified over 4,000 nanomedical clinical trials in progress now, highlighting rapid growth in the field and the need for a standardized lexicon to support clinical translation and collaboration. Nanotechnology is the science of [...]
Review: How Could Microalgal Nanoparticles Treat Cancer?
A new approach for cancer treatment involves the use of microalgal-derived nanoparticles. A recent review in Frontiers in Bioengineering and Biotechnology examines their potential as a sustainable and biocompatible solution. Promise and Limitations Nanoparticles (NPs), defined as [...]
COVID-19 models suggest universal vaccination may avert over 100,000 hospitalizations
US Scenario Modeling Hub, a collaborative modeling effort of 17 academic research institutions, reports a universal COVID-19 vaccination recommendation could avert thousands more US hospitalizations and deaths than a high-risk-only strategy. COVID-19 remains a [...]
Climate change fuels spread of neurological virus in Europe
Growing numbers of West Nile virus infection cases, fueled by climate change, are sparking fears among citizens and healthcare providers in Europe. A Clinical Insight in the European Journal of Internal Medicine, published by Elsevier, [...]
Pioneering the next-generation nanoparticle drug delivery system
Researchers report a materials breakthrough enabling a new wave of nanodrug applications, from delivery to diagnostics and gene editing, with global impact. (Nanowerk News) An Australian research team has achieved an advanced materials breakthrough [...]
New Eye Drops Sharpen Aging Eyes in Just One Hour
Imagine tossing aside your reading glasses and regaining crisp, youthful vision with just a few drops a day. New research suggests that specially formulated eye drops can significantly improve near vision in people with [...]
Scientists Use Electricity To “Reprogram” the Immune System for Faster Healing
Researchers from Trinity College Dublin have discovered that electrically stimulating 'macrophages' – one of the immune system's key players – can 'reprogramme' them in such a way to reduce inflammation and encourage faster, more [...]
Long Covid sufferers left to fend for themselves
When Alex Sprackland caught Covid-19 in March 2020, he thought he’d be back to normal in no time. Yet, five years on, the 34-year-old still grapples with the severe, life-limiting effects of the infection. [...]
New Research Reveals Nanoplastics’ Damaging Effect on Brain Cells
Researchers at Trinity Biomedical Sciences Institute (TBSI) have found that nanoplastics, which are even smaller than microplastics, impair energy metabolism in brain cells. The results were reported in the Journal of Hazardous Materials: Plastics. In addition to [...]
New research – eyedrops to lower lifetime risk of nearsightedness complications
For the first time, researchers are leading a national study to see if the onset of nearsightedness can be delayed – and consequently reduced in magnitude over a lifetime – with the use of [...]
Study Shows Brain Signals Only Matter if They Arrive on Time
Signals are processed only if they reach the brain during brief receptive cycles. This timing mechanism explains how attention filters information and may inform therapies and brain-inspired technologies. It has long been recognized that [...]
